These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Kontoyiannis DP, Boktour M, Hanna H, Torres HA, Hachem R, Raad II. Cancer; 2005 Jun 01; 103(11):2334-7. PubMed ID: 15844093 [Abstract] [Full Text] [Related]
3. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin. Aliff TB, Maslak PG, Jurcic JG, Heaney ML, Cathcart KN, Sepkowitz KA, Weiss MA. Cancer; 2003 Feb 15; 97(4):1025-32. PubMed ID: 12569602 [Abstract] [Full Text] [Related]
4. Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients. Cesaro S, Giacchino M, Locatelli F, Spiller M, Buldini B, Castellini C, Caselli D, Giraldi E, Tucci F, Tridello G, Rossi MR, Castagnola E. BMC Infect Dis; 2007 Apr 18; 7():28. PubMed ID: 17442100 [Abstract] [Full Text] [Related]
5. Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin A. Morrissey CO, Slavin MA, O'Reilly MA, Daffy JR, Seymour JF, Schwarer AP, Szer J. Mycoses; 2007 Apr 18; 50 Suppl 1():24-37. PubMed ID: 17394607 [Abstract] [Full Text] [Related]
6. Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies. Candoni A, Mestroni R, Damiani D, Tiribelli M, Michelutti A, Silvestri F, Castelli M, Viale P, Fanin R. Eur J Haematol; 2005 Sep 18; 75(3):227-33. PubMed ID: 16104879 [Abstract] [Full Text] [Related]
7. Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation. Kriván G, Sinkó J, Nagy IZ, Goda V, Reményi P, Bátai A, Lueff S, Kapás B, Réti M, Tremmel A, Masszi T. Acta Biomed; 2006 Sep 18; 77 Suppl 2():17-21. PubMed ID: 16918062 [Abstract] [Full Text] [Related]
14. Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study. Kartsonis NA, Saah AJ, Joy Lipka C, Taylor AF, Sable CA. J Infect; 2005 Apr 30; 50(3):196-205. PubMed ID: 15780413 [Abstract] [Full Text] [Related]
18. Caspofungin for invasive fungal infections: combination treatment with liposomal amphotericin B in children undergoing hemopoietic stem cell transplantation. Pancham S, Hemmaway C, New H, Albert E, Dokal I, Roberts IA, McCloy M. Pediatr Transplant; 2005 Apr 30; 9(2):254-7. PubMed ID: 15787803 [Abstract] [Full Text] [Related]
20. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis. Cesaro S, Toffolutti T, Messina C, Calore E, Alaggio R, Cusinato R, Pillon M, Zanesco L. Eur J Haematol; 2004 Jul 30; 73(1):50-5. PubMed ID: 15182338 [Abstract] [Full Text] [Related] Page: [Next] [New Search]